Lazard Transactions
DISCLAIMER: Transaction value is approximate and is based on information disclosed by the parties to the transaction or other public sources. In addition, in the case of transactions consummated in currencies other than U.S. dollars, Lazard has converted the value using the exchange rate published on the date of announcement. Lazard makes no representation or warranty with respect to the accuracy or completeness of the value provided
Download results
Showing 1 to 10 of 5965 Results
October 05, 2026
Triton Partners agrees sale of OCU Group to TDR Capital
Undisclosed
October 04, 2026
Undertaking by Delfin to tender a number of shares equal to 17.6% of the share capital of MPS in the context of ISPs Voluntary Public Exchange Offer
$6.8 Billion
October 01, 2026
Attijariwafa Bank buys into Ghana as Societe Generale exits
Undisclosed
October 01, 2026
Lazard Advised Fresenius on its Acquisition of the Remaining 45% of mAbxience, Completing Full Ownership of a Vertically Integrated Biosimilars Platform, Valuing the Company at up to €1.67 Billion
$851 Million
October 01, 2026
Corteva Announces Plan to Separate into Two Industry-Leading Public Companies
$50 Billion
September 30, 2026
Deret selects GEODIS to accelerate its growth and create a major French player in contract logistics
Undisclosed
September 30, 2026
Ashurst Perkins Coie raises a new RCF for its non-US business from a syndicate of UK and Australian banks
Undisclosed
September 28, 2026
Euroports Group Announces Agreement for A.P. Moller Capital to Acquire a Majority Stake
Undisclosed
September 23, 2026
Zymeworks to Acquire Theravance Biopharma
$929 Million
September 23, 2026